期刊文献+

HPLC Method Research of Picoplatin-a New Platinum Anti-cancer Drug and Its Impurities 被引量:1

HPLC Method Research of Picoplatin-a New Platinum Anti-cancer Drug and Its Impurities
在线阅读 下载PDF
导出
摘要 Purpose: To establish a HPLC testing method of the content of bulk picoplatin and its impurities. Method: the separation was perform on a C18 column(4.6 mm×250 mm, 5 m) with potassium dihydrogen phosphate-aceton-itrile as the mobile phase at a flow rate of 1.0 mL/min. The detecting wavelength was set at 210 nm, and the column temperature was set at 30℃. Result: in the method validation, the linear relationship modulus of picoplatin is 0.9999, the systemic precision is 0.44%, the method precision is 0.74%, the average recovery rate is 99.62%, the LOD and LOQ of picoplatin is 0.2 ng and 1.0 ng. The average resolution of picoplatin and its impurities is more than 2. Conclusion: The established method is good specificity, high sensitivity, and good repeatability which could provide scientific evidence for the quality control of picoplatin and its impurities. Purpose: To establish a HPLC testing method of the content of bulk picoplatin and its impurities. Method: the separation was perform on a C18 column(4.6 mm×250 mm, 5 μm) with potassium dihydrogen phosphate-aceton-itrile as the mobile phase at a flow rate of 1.0 mL/min. The detecting wavelength was set at 210 nm, and the column temperature was set at 30℃. Result: in the method validation, the linear relationship modulus of picoplatin is 0.9999, the systemic precision is 0.44%, the method precision is 0.74%, the average recovery rate is 99.62%, the LOD and LOQ of picoplatin is 0.2 ng and 1.0 ng. The average resolution of picoplatin and its impurities is more than 2. Conclusion: The established method is good specificity, high sensitivity, and good repeatability which could provide scientific evidence for the quality control ofpicoplatin and its impurities.
出处 《贵金属》 CAS CSCD 北大核心 2012年第A01期253-257,共5页 Precious Metals
关键词 platinum-based anti-cancer drug picoplatin HPLC platinum-based anti-cancer drug picoplatin HPLC
  • 相关文献

参考文献2

二级参考文献25

  • 1DOUILLARD JY, SCHILLER J. ZD0473 combined with other chemotherapeutic agent for the treatment of solid malignancies [ J ]. Eur J Cancer, 2002,38(Suppl) : S25 -S31.
  • 2GORA ME, ATKINSON R J, THOMAS H, et al. ZD0473 in platinum-pretreated ovarian cancer[J]. Eur J Cancer, 2002,38 ( Suppl) : S2416 - S2420.
  • 3TREAT J, SCHILLER J, QUOIX E, et al. ZD0473 treatment in lung cancer: an overview of the clinical trial results[J]. Eur J Cancer, 2002,38(Suppl) : S13 - S18.
  • 4普绍平,丛艳伟,何键,等.甲啶铂的提纯:中国,200810058602.7[P].2008-06-30.
  • 5国家药典委员会.《中国人民共和国药典》[S].二部.北京:化学工业出版社,2005:凡例,XIII-XIV.
  • 6GERALDINE M, SIMON P, PETER JS. Contrasting chemistry of cis- and trans-platinum (II) diamine anticancer compound : hydrolysis studies of picoline complexes [J]. Inorg Chem, 2005, 44 (21) : 7459 -7467.
  • 7Keith T. Flaherty,James P. Stevenson,Maryann Redlinger,Kenneth M. Algazy,Bruce Giantonio,Peter J. O’Dwyer.A phase I, dose escalation trial of ZD0473, a novel platinum analogue, in combination with gemcitabine[J]. Cancer Chemotherapy and Pharmacology . 2004 (5)
  • 8Chris Twelves,Martin Reck,Alan Anthoney,Ulrich Gatzemeier,Stan Kaye.A phase I study of ZD0473 combined with paclitaxel for the treatment of solid malignancies[J]. Cancer Chemotherapy and Pharmacology . 2003 (4)
  • 9Momekov G,Momekova D.Recent development in antitu- mor platinum coordination compounds. Expert Opin- ion . 2006
  • 10Holford J,Raynaud F,Barry A M,et al.Chemical,bio- chemical and pharmacological activity of the novel sterically hindered platinum co-ordination complex,cis-[am- minedichloro(2-methylpyridine)]platinum(Ⅱ) (AMD473). Anti Cancer Drugs . 1998

共引文献5

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部